Association Study between Serotonin 1A Receptor Gene rs6295 Polymorphism and Tardive Dyskinesia in Patients with Schizophrenia
Open Access
- 30 October 2020
- journal article
- research article
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 23 (2) , 71-77
Abstract
서 론 조현병 치료에 있어서 항정신병약물은 필수적인 약물 중에 하나로 알려져 있으며 항정신병 약물을 복용하는 환자 중 29~74% 정도에서 추체외로부작용(extrapyramidal symptoms)이 발생한다고 보고되고 있다. 1) 추체외로부작용으로는 급성 근긴장이상(acute dystonia), 정좌불능증(akathisia), 파 킨슨증(parkinsonism)과 지연성 운동이상(tardive dyskinesia)Keywords
This publication has 48 references indexed in Scilit:
- Tardive dyskinesia: Who gets it and whyParkinsonism & Related Disorders, 2019
- Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management StrategiesCNS Drugs, 2018
- Transcriptional regulation at a HTR1A polymorphism associated with mental illnessNeuropharmacology, 2008
- Autoradiographic distribution of serotonin transporters and receptor subtypes in human brainHuman Brain Mapping, 2004
- Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movementsEuropean Journal of Pharmacology, 2001
- Interactions between neuroleptics and 5-HT 1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effectsPsychopharmacology, 1999
- Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptorsNeuropharmacology, 1996
- Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissueEuropean Journal of Pharmacology, 1992
- Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesiaSchizophrenia Research, 1991